APVO
Price
$4.21
Change
+$0.33 (+8.51%)
Updated
Dec 17, 04:59 PM (EDT)
VINC
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Dec 18, 11:04 AM (EDT)
104 days until earnings call
Ad is loading...

APVO vs VINC

Header iconAPVO vs VINC Comparison
Open Charts APVO vs VINCBanner chart's image
Aptevo Therapeutics
Price$4.21
Change+$0.33 (+8.51%)
Volume$9.36K
CapitalizationN/A
Vincerx Pharma
Price$0.19
Change-$0.00 (-0.00%)
Volume$519
CapitalizationN/A
APVO vs VINC Comparison Chart
Loading...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APVO vs. VINC commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APVO is a Hold and VINC is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (APVO: $4.20 vs. VINC: $0.19)
Brand notoriety: APVO and VINC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APVO: 94% vs. VINC: 78%
Market capitalization -- APVO: $2.1M vs. VINC: $6.46M
APVO [@Biotechnology] is valued at $2.1M. VINC’s [@Biotechnology] market capitalization is $6.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APVO’s FA Score shows that 1 FA rating(s) are green whileVINC’s FA Score has 1 green FA rating(s).

  • APVO’s FA Score: 1 green, 4 red.
  • VINC’s FA Score: 1 green, 4 red.
According to our system of comparison, both APVO and VINC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APVO’s TA Score shows that 4 TA indicator(s) are bullish while VINC’s TA Score has 5 bullish TA indicator(s).

  • APVO’s TA Score: 4 bullish, 5 bearish.
  • VINC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VINC is a better buy in the short-term than APVO.

Price Growth

APVO (@Biotechnology) experienced а -54.35% price change this week, while VINC (@Biotechnology) price change was -10.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

APVO is expected to report earnings on May 09, 2024.

VINC is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VINC($6.46M) has a higher market cap than APVO($2.1M). VINC YTD gains are higher at: -83.729 vs. APVO (-98.575). APVO has higher annual earnings (EBITDA): -24.21M vs. VINC (-27.1M). VINC has more cash in the bank: 10.1M vs. APVO (1.97M). VINC has less debt than APVO: VINC (1.64M) vs APVO (4.83M). APVO (0) and VINC (0) have equivalent revenues.
APVOVINCAPVO / VINC
Capitalization2.1M6.46M33%
EBITDA-24.21M-27.1M89%
Gain YTD-98.575-83.729118%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.97M10.1M19%
Total Debt4.83M1.64M295%
FUNDAMENTALS RATINGS
APVO: Fundamental Ratings
APVO
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APVOVINC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMRN67.191.65
+2.52%
BioMarin Pharmaceutical
SDA8.840.08
+0.91%
SunCar Technology Group
SBFM2.740.02
+0.74%
Sunshine Biopharma Inc
FL22.26-0.23
-1.02%
Foot Locker
SFWL1.05-0.02
-1.87%
Shengfeng Development Limited

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with GOSS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
+8.25%
GOSS - APVO
42%
Loosely correlated
+1.71%
CYTK - APVO
36%
Loosely correlated
-2.53%
ENLV - APVO
36%
Loosely correlated
+1.72%
VINC - APVO
34%
Loosely correlated
-0.31%
AXON - APVO
33%
Loosely correlated
-2.09%
More

VINC and

Correlation & Price change

A.I.dvisor indicates that over the last year, VINC has been loosely correlated with INKT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VINC jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VINC
1D Price
Change %
VINC100%
-0.31%
INKT - VINC
39%
Loosely correlated
-7.12%
APVO - VINC
33%
Loosely correlated
+8.25%
RNA - VINC
31%
Poorly correlated
-1.95%
VNDA - VINC
30%
Poorly correlated
+2.16%
IOVA - VINC
30%
Poorly correlated
-0.38%
More